CF PharmTech Inc HKEX:2652:
STRATEGIC COOPERATION WITH JD HEALTH
JD HEALTH TO BE EXCLUSIVE ONLINE LAUNCH PLATFORM FOR MAJOR NEW PRODUCTS FOR THREE YEARS
CF Pharmtech Announces Strategic Cooperation With JD Health
Watch JD Health International's latest callJD Health International (HKEX:6618) Q2 2026 Earnings Call · Replay · Aug 13Read the transcript of JD Health International (HKEX:6618) Q2 2026 Earnings CallJD Health International, Inc. on 6ix
Earlier from JD Health International
- JD Health International: Record revenue and profit growth driven by AI healthcare expansion and omnichannel strategy
- Hong Kong shares fall after Lunar New Year break, tech drops
- Asia report: Defence plays lead gains across the region
- JD Health International Posts Qtrly Non-IFRS Profit RMB1.90 Billion
- JD Health International Says Enlin Jin Resigns As Executive Director, CEO
Later from JD Health International
- JD Health's Revenue Growth Likely Slowed in First Quarter — Market Talk
- Chinese Biopharma Stocks Rally as Investors Favor Healthcare Over AI
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow JD Health International into a list and get an email when it puts out news.
Follow JD Health International